No More Tool Hopping: eVa by eWizard Unifies Life Sciences Content Workflows

eVa Brings All-in-One AI Power to Life Sciences Teams

eWizard, the content experience platform by Viseven, today announces the launch of eVa — a purpose-built AI agent created to meet the demands of marketing and medical teams in the pharmaceutical and life sciences industries. 

eVa revolutionizes how these teams create, adapt, and validate content by automating complex workflows and significantly accelerating the Medical-Legal-Review (MLR) process. In just minutes, eVa generates complete content layouts — from rep-triggered emails to full e-Detailer decks — with on-brand copy, visuals, and structure. It connects directly to digital asset management (DAM) systems and performs pre-checks to support compliance from the very first draft. 

How eVa Works 

Pharma and life sciences marketing teams often work across disconnected systems — writing text in one tool, building visuals in another, and compliance tracked in spreadsheets. This creates weeks of back-and-forth between creative teams, compliance and medical, and external agencies.   

eVa reduces the need to switch between multiple tools by guiding teams through the entire process — from briefing to approval. Users can give eVa a simple prompt or an existing template to generate a full content layout. The AI Agent automatically pulls approved text snippets from a user’s DAM system and suggests context-relevant images.  

When a user’s DAM doesn’t have what is needed, eVa generates new copy or custom visuals, clearly labeling everything as “AI-generated.” Before content leaves the platform, eWizard’s MLR agent flags potential compliance issues and suggests corrections, reducing the review cycles that typically slow down go-to-market time.  

The value behind eVa builds on an already recognized foundation — in June 2025, the eWizard platform was named a Gold Globee® Award Winner for Most Innovative Product of the Year, highlighting its role in helping life sciences organizations overcome some of the industry’s toughest challenges — from speeding up MLR review cycles, to reducing manual tasks like asset tagging, and enabling true omnichannel orchestration. 

“We built eVa not just to speed up content creation, but to build trust in the process. Compliance is a conversation, not a checkbox — and eVa brings that conversation into the heart of the workflow.” 

— Dan Atieh, Head of Product, eWizard 

Take a look at what eVa can do for you 

See how eVa AI Content Agent resolves real-life pharma content challenges in a workflow just like yours. 

Book my demo

Why This Approach Makes Sense 

eVa works because it doesn’t ask teams to change how they work or adopt new platforms. It simply integrates into the platform many pharmaceutical teams already use.  

Users automatically leverage brand-approved assets, ensuring consistency and compliance. Localization becomes simpler, adapting content efficiently without starting from scratch. Campaign launches move faster while maintaining compliance and message integrity. 

In regulated industries like life sciences, professionals need AI that gets the balance between moving fast and staying compliant. That’s what eWizard is aiming for with eVa AI Agent. 

See eVa in Action 

Viseven is a global technology and service provider specializing in digital content solutions for the Life Sciences industry. With over 15 years of expertise, Viseven empowers life sciences companies, like pharma and medtech, and their production agencies with AI-driven content management and automation solutions. 

About eWizard 

eWizard is an AI-powered content lifecycle platform by Viseven designed specifically for pharma and life sciences teams. It streamlines end-to-end content creation, management, and distribution, ensuring brand compliance while accelerating time-to-market. By combining AI with deep industry expertise, eWizard empowers marketers to produce high-impact omnichannel campaigns faster and more efficiently. 

Learn more about eWizard’s capabilities

Check out eWizard and its suite of tools that take your commercialization efforts to the next level.

Learn more